ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today ...

In his previous role as the National Sales Head he played a vital role in strengthening News 24’s market presence ...

SALES: The London-listed group's third-quarter sales are forecast at ... coming months and materially harm Chinese sales for the next few years, taking cues from GSK's 2013 Chinese bribery scandal, ...

Profit at the UK arm of software giant Workday almost doubled during its latest financial year, it has been revealed.

By enhancing DEI strategies, UK firms can set themselves apart, fostering inclusivity that drives growth – Reshma Sheikh ...

The US group's division has reported a pre-tax profit of $39.5m (£30.6m) for the 12 months to 31 January, 2024, according to ...

In its third quarter results of 2024, pharmaceutical giant GSK confirmed it would pay a quarterly dividend of 15 pence. However, Morningstar analyst Christopher Johnson says he believes that GSK’s ...

Astrazeneca is set to report earnings next week after a turbulant few months for the FTSE 100 firm and its China arm.

This looks like an appealing, diversified option for dividends. The post One high-yield ASX dividend ETF to buy to generate ...

LEMSIP and other popular cold and flu tablets should be pulled from Britain’s shelves because they don’t work, experts have ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

Animal testing remains widespread, but the long history of campaigning against it has made some inroads, with some sectors pioneering alternative methods and scientists highlighting its shortcomings.A ...